NephrAmine 5.4% Side Effects
Please note - some side effects for NephrAmine 5.4% may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
NephrAmine 5.4% Side Effects - for the Professional
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis, and hypervolemia.
Symptoms may result from an excess or deficit of one or more of the ions present in the solution infused, therefore, frequent monitoring of electrolyte levels is essential.
Infrequent instances of hyperammonemia have been reported following administration of essential amino acid solutions to patients with massive gastrointestinal hemorrhage, nonuremic infants and pediatric patients or following administration of higher than recommended doses to adult or pediatric patients. Elevated plasma amino acid levels (hypermethionemia) have also been reported in infants especially in higher dosage ranges. Elevated serum ammonia levels, plasma amino acid levels, and clinical symptoms may subside when the infusions are discontinued.
Phosphorus deficiency may lead to impaired tissue oxygenation and acute hemolytic anemia. Relative to calcium, excessive phosphorus intake can precipitate hypocalcemia with cramps, tetany, and muscular hyperexcitability.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.
- Aminosyn Prescribing Information (FDA)
- Aminosyn-HBC Prescribing Information (FDA)
- Aminosyn-HF Prescribing Information (FDA)
- Aminosyn-RF Prescribing Information (FDA)
- BranchAmin Prescribing Information (FDA)
- FreAmine HBC Prescribing Information (FDA)
- FreAmine III Prescribing Information (FDA)
- HepatAmine Prescribing Information (FDA)
- Novamine Prescribing Information (FDA)
- Premasol Prescribing Information (FDA)
- ProSol Prescribing Information (FDA)
- RenAmin Prescribing Information (FDA)
- TrophAmine Prescribing Information (FDA)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.